Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Sharecast News) - Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% efficacy rate.
Read more
LONDON, Dec 30 (Reuters) - One dose of Oxford/AstraZeneca's COVID-19 vaccine is around 70% effective after 21 days and before the second dose is given, a British doctor involved in the approval of the vaccine said on Wednesday."The data shared wit...
Read more(Adds report on lockdown extension)By Kirsti Knolle and Douglas BusvineBERLIN, Dec 30 (Reuters) - Germany expects the European Union to give rapid approval to the coronavirus vaccine developed by Oxford University and AstraZeneca that was cleared ...
Read more(Adds detail from Health Ministry on Pfizer/BioNTech vaccine deliveries)By Kirsti Knolle and Douglas BusvineBERLIN, Dec 30 (Reuters) - Germany expects the European Union to give rapid approval to the coronavirus vaccine developed by Oxford Univers...
Read more(Updates with context on German vaccination campaign, COVID-19 stats)By Kirsti Knolle and Douglas BusvineBERLIN, Dec 30 (Reuters) - Germany expects the European Union to give rapid approval to the coronavirus vaccine developed by Oxford University...
Read more(Adds quote)BERLIN, Dec 30 (Reuters) - Germany expects the European Union to give quick approval to the coronavirus vaccine developed by Oxford University and Astrazeneca that was cleared for use in Britain on Wednesday, its top vaccines official...
Read moreBERLIN, Dec 30 (Reuters) - Germany expects the European Union to give quick approval to the coronavirus vaccine developed by Oxford University and Astrazeneca that was cleared for use in Britain on Wednesday, its top vaccines official said.Klaus ...
Read moreLONDON, Dec 30 (Reuters) - Oxford and AstraZeneca's COVID-19 vaccine can be 80% effective when there are three months between shots, an official involved in approving the vaccine in Britain said, but there is insufficient evidence to back a regime...
Read more
UK WINNERS & LOSERS SUMMARY: Astra Up On Covid Vaccine Approval In UK
Read more(Repeats to change `Wrapup 3' to `Wrapup 4'. No change in text.)* World stocks up 14% this year, 70% from March lows* Euro hits highest since April 2018 vs dollar* AstraZeneca vaccine approval in Britain boosts UK assets* Graphic: 2020 asset perform...
Read more* Miners weigh down FTSE 100* Spain's Unicaja jumps on Liberbank merger* Thin volumes keep markets volatile (Updates to market close)By Sruthi Shankar and Ambar WarrickDec 30 (Reuters) - European stocks ended a five-day winning streak on Wednesday ...
Read more* World stocks up 14% this year, 70% from March lows* Euro hits highest since April 2018 vs dollar* AstraZeneca vaccine approval in Britain boosts UK assets* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn* Graphic: World FX rates in 2020 ht...
Read moreBERLIN, Dec 30 (Reuters) - The still high COVID-19 infection numbers do not allow a back to normal for now, German Health Minister Jens Spahn said on Wednesday.Following Wednesday's approval of a coronavirus vaccine developed by Oxford University ...
Read moreUK BROKER RATINGS SUMMARY: Alphavalue Lifts Astra To Add From Reduce
Read more* UK imposes more lockdowns* AstraZeneca COVID-19 vaccine gets UK nod* Brexit deal passes parliament vote* British house prices rise the most in six years* FTSE 100 falls 0.7%, FTSE 250 down 0.9% (Updates to market close)By Shivani KumaresanDec 30 (...
Read more
Last checked at